Literature DB >> 19302753

Severity of sepsis is correlated with the elevation of serum high-mobility group box 1 in rats.

Li-chao Hou1, Ming-zhe Qin, Li-na Zheng, Yan Lu, Qiang Wang, Dao-rong Peng, Xin-ping Yu, Yu-chang Xin, Gen-lin Ji, Li-ze Xiong.   

Abstract

BACKGROUND: Sepsis is a leading cause of death in the intensive care units. The late inflammatory cytokine, high-mobility group box 1 (HMGB1), plays a critical role in sepsis. In the present study, we investigated the association between the serum HMGB1 levels and the severity of organ injury in the lipopolysaccharide-induced sepsis in rats.
METHODS: To produce an animal model of sepsis with different degree of organ injury, animals were treated with three different doses of lipopolysaccharide (4, 8 and 16 mg/kg), and the animals in control group were treated with the same volume of the vehicle (saline). The levels of serum HMGB1 were measured at 0, 2, 4, 8, 16, 24, 32 and 48 hours after lipopolysaccharide (LPS) or vehicle injection, meanwhile the biochemical and histopathological indicators for the severity of organ injury were assessed.
RESULTS: The level of HMGB1 had a positive, high correlation with the abnormal changes of serum cardiac troponin I, alanine aminotransferase, aspartate aminotransferase, creatinine and blood urea nitrogen, as well as the pathologic scores of heart, lung, liver and kidney.
CONCLUSIONS: The level of serum HMGB1 is highly correlated with the severity of sepsis in rats, suggesting that HMGB1 could serve as a valuable adjunct in the diagnosis and management of sepsis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19302753

Source DB:  PubMed          Journal:  Chin Med J (Engl)        ISSN: 0366-6999            Impact factor:   2.628


  8 in total

1.  Metformin inhibits HMGB1 release in LPS-treated RAW 264.7 cells and increases survival rate of endotoxaemic mice.

Authors:  Konstantin Tsoyi; Hwa Jin Jang; Irina Tsoy Nizamutdinova; Young Min Kim; Young Soo Lee; Hye Jung Kim; Han Geuk Seo; Jae Heun Lee; Ki Churl Chang
Journal:  Br J Pharmacol       Date:  2011-04       Impact factor: 8.739

2.  Resolvin D1 improves survival in experimental sepsis through reducing bacterial load and preventing excessive activation of inflammatory response.

Authors:  F Chen; X H Fan; Y P Wu; J L Zhu; F Wang; L L Bo; J B Li; R Bao; X M Deng
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-09-27       Impact factor: 3.267

3.  Combination therapy of molecular hydrogen and hyperoxia improves survival rate and organ damage in a zymosan-induced generalized inflammation model.

Authors:  Yunchuan Hong; L I Sun; Ruiqiang Sun; Hongguang Chen; Yonghao Yu; Keliang Xie
Journal:  Exp Ther Med       Date:  2016-04-06       Impact factor: 2.447

4.  Resolvin D1 Promotes SIRT1 Expression to Counteract the Activation of STAT3 and NF-κB in Mice with Septic-Associated Lung Injury.

Authors:  Yuzhen Zhuo; Shukun Zhang; Caixia Li; Lei Yang; Hongwei Gao; Ximo Wang
Journal:  Inflammation       Date:  2018-10       Impact factor: 4.092

5.  Increased HMGB1 expression and release by mononuclear cells following surgical/anesthesia trauma.

Authors:  Valeria Manganelli; Michele Signore; Ilaria Pacini; Roberta Misasi; Guglielmo Tellan; Tina Garofalo; Emanuela Lococo; Piero Chirletti; Maurizio Sorice; Giovanna Delogu
Journal:  Crit Care       Date:  2010-11-02       Impact factor: 9.097

6.  The Effects of Remifentanil on Expression of High Mobility Group Box 1 in Septic Rats.

Authors:  Kwon Hui Seo; Jin Woo Choi; Hong Soo Jung; Hansol Yoo; Jin Deok Joo
Journal:  J Korean Med Sci       Date:  2017-03       Impact factor: 2.153

7.  Sub-anesthesia Dose of Isoflurane in 60% Oxygen Reduces Inflammatory Responses in Experimental Sepsis Models.

Authors:  Yi Huang; Xiao-Xia Wang; Dong-Dong Sun; Ze-Xin Zhang; Wan-Wan Yang; Tian Shao; Han Han; Er-Fei Zhang; Zhong-Shu Pu; Zuo-Xu Hou; Hai-Long Dong; Li-Ze Xiong; Li-Chao Hou
Journal:  Chin Med J (Engl)       Date:  2017-04-05       Impact factor: 2.628

8.  The protective effect of lidocaine on septic rats via the inhibition of high mobility group box 1 expression and NF-κB activation.

Authors:  Huan-Liang Wang; Yan-Qiu Xing; Ying-Xue Xu; Fei Rong; Wei-Fu Lei; Wen-Hua Zhang
Journal:  Mediators Inflamm       Date:  2013-11-25       Impact factor: 4.711

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.